We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+15.46%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.97B
AUM Growth
+$823M
Cap. Flow
+$400M
Cap. Flow %
8.04%
Top 10 Hldgs %
46.77%
Holding
94
New
22
Increased
21
Reduced
16
Closed
33

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$384M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$238M
3
AGN
Allergan plc
AGN
+$175M
4
MDVN
MEDIVATION, INC.
MDVN
+$122M
5
AMZN icon
Amazon
AMZN
+$105M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$174M
2
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
+$106M
3
GILD icon
Gilead Sciences
GILD
+$106M
4
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$104M
5
DG icon
Dollar General
DG
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 39.81%
2 Communication Services 12%
3 Real Estate 9.46%
4 Energy 7.24%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYGN icon
51
Myriad Genetics
MYGN
$476M
$8.52M 0.17%
406,103
+258,727
+176% +$6.54M
RLYP
52
DELISTED
RELYPSA INC COM
RLYP
$8.04M 0.16%
+321,527
New +$6.6M
SCAI
53
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$7.54M 0.15%
+216,360
New +$6.61M
OCR
54
DELISTED
OMNICARE INC
OCR
$7.45M 0.15%
+123,428
New +$7.07M
BHC icon
55
Bausch Health
BHC
$1.75B
$7.3M 0.15%
62,148
-160
-0.3% -$17.5K
BLUE
56
DELISTED
bluebird bio
BLUE
$6.17M 0.12%
22,722
+7,444
+49% +$2.08M
DNDN
57
DELISTED
DENDREON CORPORATION
DNDN
$6M 0.12%
+2,007,813
New +$5.65M
BMY icon
58
CALL
Bristol-Myers Squibb
BMY
$129B
$2.88M 0.06%
+2,045,500
New +$104M
MGNX icon
59
MacroGenics
MGNX
$233M
$2.33M 0.05%
+84,846
New +$2.22M
AAPL icon
60
Apple
AAPL
$4.97T
– –
-3,021,760
Closed -$51.5M
AGIO icon
61
Agios Pharmaceuticals
AGIO
$2.08B
– –
-206,829
Closed -$5.78M
CI icon
62
Cigna
CI
$78.4B
– –
-201,492
Closed -$15.5M
JCI icon
63
Johnson Controls International
JCI
$85.1B
– –
-910,196
Closed -$39.6M
LOW icon
64
Lowe's Companies
LOW
$121B
– –
-1,418,185
Closed -$67.5M
MOH icon
65
Molina Healthcare
MOH
$10.4B
– –
-250,989
Closed -$8.94M
MRK icon
66
CALL
Merck
MRK
$322B
– –
-480,718
Closed -$101K
MRK icon
67
Merck
MRK
$322B
– –
-408,047
Closed -$18.5M
MTG icon
68
MGIC Investment
MTG
$6.47B
– –
-4,547,872
Closed -$33.1M
MYGN icon
69
CALL
Myriad Genetics
MYGN
$476M
– –
-194,000
Closed -$87K
SCHW
70
Charles Schwab
SCHW
$182B
– –
-2,125,377
Closed -$44.9M
TDC icon
71
Teradata
TDC
$2.88B
– –
-674,137
Closed -$37.4M
TEX icon
72
Terex
TEX
$7.37B
– –
-1,264,391
Closed -$42.5M
VIPS icon
73
Vipshop
VIPS
$7.26B
– –
-7,051,490
Closed -$40.1M
VTRS icon
74
Viatris
VTRS
$20.8B
– –
-233,887
Closed -$8.93M
WAT icon
75
CALL
Waters Corp
WAT
$37.3B
– –
-329,600
Closed -$470K
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2013 Portfolio in Review

As of Q4 2013, PFM Health Sciences held 94 positions worth $4.97B, up 20% from $4.15B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

PFM Health Sciences deployed $400M of net new capital in Q4 2013, opening 22 new positions and adding to 21 existing holdings. Its largest new stake was Bristol-Myers Squibb: 7,532,007 shares worth $400M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 34% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $174M trimmed.

  • PFM Health Sciences's largest Q4 2013 buy was Bristol-Myers Squibb: 7,532,007 shares worth $400M.
  • PFM Health Sciences added most to Allergan plc in Q4 2013, an estimated $175M increase.
  • PFM Health Sciences's biggest Q4 2013 reduction was Thermo Fisher Scientific, cutting an estimated $174M.
  • PFM Health Sciences fully exited CAMERON INTERNATIONAL CORPORATION in Q4 2013, selling an estimated $106M.
  • PFM Health Sciences's ten largest holdings make up 47% of its $4.97B portfolio in Q4 2013.
  • PFM Health Sciences opened 22 new positions and closed 33 in Q4 2013.
  • PFM Health Sciences's portfolio value rose 20% quarter-over-quarter to $4.97B.

Based on PFM Health Sciences's 13F filing for Q4 2013, filed 14 Feb 2014.